Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference.
Bernardo Sousa-PintoHolger J SchünemannAna Sá-SousaRafael José VieiraRita AmaralJosep M AntoLudger KlimekWienczyslawa CzarlewskiJoaquim MullolOliver PfaarAnna BedbrookLuisa BrussinoVioleta KvedarieneDésirée Erlinda Larenas-LinnemannYoshitaka OkamotoMaria Teresa VenturaIoana AgacheIgnacio J AnsoteguiKarl C BergmannSinthia Bosnic-AnticevichJan BrozekG Walter CanonicaVictoria CardonaPedro Carreiro-MartinsThomas CasaleLorenzo CecchiTomas ChivatoDerek K ChuCemal CingiElísio M CostaÁlvaro Augusto CruzStefano Del GiaccoPhilippe DevillierPatrik EklundWytske J FokkensBilun GemiciogluTari HaahtelaJuan Carlos IvancevichZhanat IspayevaMarek JutelPiotr KunaIgor KaidashevKhaitov M RHelga KraxnerDaniel LauneBrian LipworthRenaud LouisMichael MakrisRiccardo MontiMario Morais-AlmeidaRalph MösgesMarek NiedoszytkoPapadopoulos G NikolaosVincenzo PatellaNhân Pham-ThiFrederico S RegateiroSietze ReitsmaPhilip W RouadiBoleslaw SamolinskiAziz SheikhMilan SovaAna Todo-BomLuis Taborda-BarataSanna Toppila-SalmiJoaquin SastreIoanna TsiligianniArunas ValiulisOlivier VandenplasDana WallaceSusan WasermanArzu YorganciogluMihaela ZidarnTorsten ZuberbierJoão Almeida FonsecaJean BousquetPublished in: Allergy (2022)
Median VAS levels were higher in co-medication than in monotherapy. Patients with more severe symptoms report a higher treatment, which is currently not reflected in guidelines.